124 related articles for article (PubMed ID: 23106220)
1. Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreak.
Azuma T; Nakada N; Yamashita N; Tanaka H
Environ Sci Technol; 2012 Dec; 46(23):12873-81. PubMed ID: 23106220
[TBL] [Abstract][Full Text] [Related]
2. Mass balance of anti-influenza drugs discharged into the Yodo River system, Japan, under an influenza outbreak.
Azuma T; Nakada N; Yamashita N; Tanaka H
Chemosphere; 2013 Nov; 93(9):1672-7. PubMed ID: 23871592
[TBL] [Abstract][Full Text] [Related]
3. Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in Japan.
Azuma T; Ishiuchi H; Inoyama T; Teranishi Y; Yamaoka M; Sato T; Yamashita N; Tanaka H; Mino Y
PLoS One; 2015; 10(6):e0131412. PubMed ID: 26110817
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants.
Ghosh GC; Nakada N; Yamashita N; Tanaka H
Chemosphere; 2010 Sep; 81(1):13-7. PubMed ID: 20692015
[TBL] [Abstract][Full Text] [Related]
5. Prediction, risk and control of anti-influenza drugs in the Yodo River Basin, Japan during seasonal and pandemic influenza using the transmission model for infectious disease.
Azuma T; Nakada N; Yamashita N; Tanaka H
Sci Total Environ; 2015 Jul; 521-522():68-74. PubMed ID: 25828414
[TBL] [Abstract][Full Text] [Related]
6. Fate of new three anti-influenza drugs and one prodrug in the water environment.
Azuma T; Ishida M; Hisamatsu K; Yunoki A; Otomo K; Kunitou M; Shimizu M; Hosomaru K; Mikata S; Mino Y
Chemosphere; 2017 Feb; 169():550-557. PubMed ID: 27898328
[TBL] [Abstract][Full Text] [Related]
7. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
Straub JO
Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
[TBL] [Abstract][Full Text] [Related]
8. Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan.
Ghosh GC; Nakada N; Yamashita N; Tanaka H
Environ Health Perspect; 2010 Jan; 118(1):103-7. PubMed ID: 20056566
[TBL] [Abstract][Full Text] [Related]
9. Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic.
Leknes H; Sturtzel IE; Dye C
Sci Total Environ; 2012 Jan; 414():632-8. PubMed ID: 22127154
[TBL] [Abstract][Full Text] [Related]
10. Antiviral pandemic risk assessment for urban receiving waters.
Ellis JB
Water Sci Technol; 2010; 61(4):879-84. PubMed ID: 20182065
[TBL] [Abstract][Full Text] [Related]
11. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
12. The environmental fate of the antiviral drug oseltamivir carboxylate in different waters.
Bartels P; von Tümpling W
Sci Total Environ; 2008 Nov; 405(1-3):215-25. PubMed ID: 18675443
[TBL] [Abstract][Full Text] [Related]
13. Detection of the antiviral drug oseltamivir in aquatic environments.
Söderström H; Järhult JD; Olsen B; Lindberg RH; Tanaka H; Fick J
PLoS One; 2009 Jun; 4(6):e6064. PubMed ID: 19557131
[TBL] [Abstract][Full Text] [Related]
14. Pandemic pharmaceutical dosing effects on wastewater treatment: no adaptation of activated sludge bacteria to degrade the antiviral drug oseltamivir (Tamiflu®) and loss of nutrient removal performance.
Slater FR; Singer AC; Turner S; Barr JJ; Bond PL
FEMS Microbiol Lett; 2011 Feb; 315(1):17-22. PubMed ID: 21133989
[TBL] [Abstract][Full Text] [Related]
15. Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems.
Saccà ML; Accinelli C; Fick J; Lindberg R; Olsen B
Chemosphere; 2009 Mar; 75(1):28-33. PubMed ID: 19124147
[TBL] [Abstract][Full Text] [Related]
16. [Antiinfluenza-drugs and the standard of the use].
Matsumoto K
Nihon Rinsho; 2000 Nov; 58(11):2283-7. PubMed ID: 11225318
[TBL] [Abstract][Full Text] [Related]
17. Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.
Zaraket H; Saito R; Wakim R; Tabet C; Medlej F; Reda M; Baranovich T; Suzuki Y; Dapat C; Caperig-Dapat I; Dbaibo GS; Suzuki H
J Med Virol; 2010 Jul; 82(7):1224-8. PubMed ID: 20513088
[TBL] [Abstract][Full Text] [Related]
18. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
[TBL] [Abstract][Full Text] [Related]
19. Reassessing the risks of Tamiflu use during a pandemic to the Lower Colorado River.
Singer AC; Johnson AC; Anderson PD; Snyder SA
Environ Health Perspect; 2008 Jul; 116(7):A285-A286. PubMed ID: 18629328
[No Abstract] [Full Text] [Related]
20. Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review.
Jackson RJ; Cooper KL; Tappenden P; Rees A; Simpson EL; Read RC; Nicholson KG
J Infect; 2011 Jan; 62(1):14-25. PubMed ID: 20950645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
